Uniphar announced today that it launched three new state-of-the-art facilities to expand its international presence. The company unveiled new facilities in Raleigh, North Carolina, Lelystad, the Netherlands, and Dublin, Ireland. It says the facilities mark its commitment to enhancing logistics and distribution capabilities within the global pharmaceutical and healthcare sectors. Uniphar said the locations position…

GE HealthCare (Nasdaq: GEHC) announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, Ireland. The company plans to expand with a new, state-of-the-art facility on the existing grounds of the Carrigtohill, Cork, site. It anticipates 25 million more patient doses per year of contrast media by the end of…

The PHARMAP 2025 Congress, marking its fiftgh anniversary, is expected to convene 350 pharmaceutical manufacturing specialists, technology innovators, and industry leaders from April 14-15, 2025 in Berlin . The event will draw global pharmaceutical firms including Bayer, MSD, F. Hoffmann-La Roche, and GSK. IT will feature more than 57 speakers across specialized tracks, including pharmaceutical…

Facility design challenges for small biopharma startups For small biopharma startups, the leap from groundbreaking discoveries in the lab to full-scale drug production is both exhilarating and daunting. While scientific innovation drives initial success, translating laboratory methods into manufacturing processes presents challenges beyond technical expertise.  For all of the hurdles both compliance and technical rigor…

Nelipak announced today that it received International Sustainability and Carbon Certification (ISCC) Plus for its Derry, Northern Ireland facility. ISCC PLUS is a globally recognized standard tracking recycled and bio-based materials through the supply chain. It verifies that companies meet environmental and social standards. Cranston, Rhode Island-based Nelipak manufactures healthcare packaging solutions and offers complementary…

Aragen announced that it received a $100 million investment to support the expansion of its pharmaceutical outsourcing services. Quadria Capital, an Asian healthcare-focused private equity fund, made the investment. This results in the company acquiring a minority stake in Aragen, primarily through a fresh capital infusion. A small portion comes from the sale of shares…

Purdue University, Eli Lilly and Co., and Merck & Co. have launched the Young Institute Pharmaceutical Manufacturing Consortium, a collaborative effort to pioneer advances in making medicines. Operating within Purdue’s William D. and Sherry L. Young Institute for Advanced Manufacturing of Pharmaceuticals, consortium partners will focus on advancing pharmaceutical manufacturing, according to a Jan. 17 news…

Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Rahway, New Jersey–based Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings…

PharmaEssentia has reaffirmed its commitment to creating access to critical interferon therapies amid a reported global shortage. The Burlington, Massachusetts-based company noted a recent reported shortage of Pegasys (peginterferon alfa-2a), a treatment for hepatitis C and B. With concerns growing over drug shortages for other therapies, the company said its established cGMP manufacturing network and…

An African Union effort to strengthen public health and improve vaccine access in Africa has received a $45 million financing package. The U.S. International Development Finance Corporation, the African Development Bank and the International Finance Corporation (IFC) jointly announced the package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD). This agreement underscores…